Dr. Benjamin Thayne Larson, MD

Dr. Larson practices at Temecula Valley Day Surgery - Murrieta in Murrieta, California.

Dr. Larson's NPI, 1972747988, was assigned on April 22, 2009. Dr. Larson graduated from Cleveland Medical College, Homeopathic in 2009. Dr. Larson holds California license A136009.

Dr. Larson's primary practice is Temecula Valley Day Surgery - Murrieta, at 25495 Medical Center Dr, Ste 101, Murrieta, CA 92562. The practice phone is (951) 200-7777.

Dr. Larson's primary practice is Temecula Valley Day Surgery - Murrieta in Murrieta, California. Dr. Larson is also affiliated with Southwest Healthcare Rancho Springs Hospital. The medical group on file is Tri-Valley Urology Medical Group. Dmand AI also links Dr. Larson to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Larson practices, 5 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Larson's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Larson is board certified in urology by the American Board of Urology. Dmand AI has Dr. Larson's licenses on file in 2 states: California and Ohio.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and pelvic prolapse among the conditions Dr. Larson treats.

CMS data shows 7,052 Medicare services from Dr. Larson across 24 procedure codes in 2024, for 621 Medicare patients. Medicare paid $242,396 for them. Every service was in an office.

CMS counts 621 Medicare patients who saw Dr. Larson in 2024. The largest group is 65 to 74, with 285 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.28, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Larson's median patient age at 72, with 16% women.

In 2024, Dr. Larson wrote 1,751 Medicare Part D claims for 608 patients. 79% of them were for generic drugs. CMS names the drug for 1,630 of them, across 27 drugs with 11 or more claims each, at $1,719,577 in total drug cost. In 2023, CMS named 1,259 claims across 24 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Larson for performance year 2024, reported as part of a group. Dr. Larson accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 17 papers to Dr. Larson, published from 2006 to 2015. 2006 was the busiest year, with 2. The most frequent topics are Prostatic Hyperplasia, Transurethral Resection of Prostate and Kidney Neoplasms. Dr. Larson has published most often in J Urol. Dr. Larson's most frequent co-authors are Steven Campbell, MD, David G. Bostwick, MD, MBA and Amr F. Fergany, MD.

Dmand AI links Dr. Larson to 1 clinical trial. Conditions studied include Urinary Incontinence, Stress and Urinary Incontinence.

CMS Open Payments shows 397 general payments to Dr. Larson from 57 drug and device companies from 2016 to 2025. Ownership or investment make up the largest share, 96% of the total. Boston Scientific Corporation paid the most, $318,618.

Dr. Larson graduated from Cleveland Medical College, Homeopathic in 2009.

Dr. Larson is in network with 12 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.